nach oben

Clinical Pharmacokinetics

Erschienen in:

01.03.2009 | Review Article

Sex Differences in Pharmacokinetics and Pharmacodynamics

verfasst von: Dr Offie P. Soldin, Donald R. Mattison

Erschienen in: Clinical Pharmacokinetics | Ausgabe 3/2009

Einloggen, um Zugang zu erhalten

Abstract

Significant differences that exist between the sexes affect the prevalence, incidence and severity of a broad range of diseases and conditions. Men and women also differ in their response to drug treatment. It is therefore essential to understand these reactions in order to appropriately conduct risk assessment and to design safe and effective treatments. Even from that modest perspective, how and when we use drugs can result in unwanted and unexpected outcomes. This review summarizes the sex-based differences that impact on pharmacokinetics, and includes a general comparison of clinical pharmacology as it applies to men, women and pregnant women. Sex-related or pregnancy-induced changes in drug absorption, distribution, metabolism and elimination, when significant, may guide changes in dosage regimen or therapeutic monitoring to increase its effectiveness or reduce potential toxicity. Given those parameters, and our knowledge of sex differences, we can derive essentially all factors necessary for therapeutic optimization.

Since this is a rapidly evolving area, it is essential for the practitioner to review drug prescribing information and recent literature in order to fully understand the impact of these differences on clinical therapeutics.

Hardman JG, Limbird LE, Gilman AG. Goodman & Gilman’s the pharmacological basis of therapeutics. New York: McGraw-Hill, 2001

Messing K, Mager Stellman J. Sex, gender and women’s occupational health: the importance of considering mechanism. Environ Res 2006 Jun; 101(2): 149–62PubMedCrossRef

Zahm SH, Blair A, Weisenburger DD. Sex differences in the risk of multiple myeloma associated with agriculture. Br J Ind Med 1992 Nov; 49(11): 815–6PubMed

Ogden CL, Fryar CD, Carroll MD, et al. Mean body weight, height, and body mass index, United States 1960–2002: advance data from vital and health statistics; no. 347. Hyattsville (MD): National Center for Health Statistics, 2004 Oct 27 [online]. Available from URL: http://www.cdc.gov/nchs/data/ad/ad347.pdf [Accessed 2008 Dec 4]

Wizemann TM, Pardue ML, editors. Exploring the biological contributions to human health: does sex matter? Washington, DC: National Academies Press, 2001 [online]. Available from URL: http://www.nap.edu/catalog.php?record_id=10028#toc [Accessed 2009 Feb 12]

Marrocco A, Stewart DE. We’ve come a long way, maybe: recruitment of women and analysis of results by sex in clinical research. J Womens Health Gend Based Med 2001 Mar; 10(2): 175–9PubMedCrossRef

Office of Research on Women’s Health and NIH Support for Research on Women’s Health Issues. Report of the Advisory Committee on Research on Women’s Health; fiscal years 2005 & 2006 [online]. Available from URL: http://orwh.od.nih.gov/pubs/complete_ICD_report05_06.pdf [Accessed 2008 Dec 4]

US General Accounting Office (GAO). Drug safety: most drugs withdrawn in recent years had greater health risks for women. Washington, DC: GAO, 2001 Jan 19 [online]. Available from URL: www.gao.gov/new.items/d01286r.pdf [Accessed 2008 Dec 4]

Byrne J. Infertility and premature menopause in childhood cancer survivors. Med Pediatr Oncol 1999 Jul; 33(1): 24–8PubMedCrossRef

10.

Gorski JC, Vannaprasaht S, Hamman MA, et al. The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity. Clin Pharmacol Ther 2003 Sep; 74(3): 275–87PubMedCrossRef

11.

Vukovich RA, Brannick LJ, Sugerman AA, et al. Sex differences in the intramuscular absorption and bioavailability of cephradine. Clin Pharmacol Ther 1975 Aug; 18(2): 215–20PubMed

12.

Gandhi M, Aweeka F, Greenblatt RM, et al. Sex differences in pharmacokinetics and pharmacodynamics. Annu Rev Pharmacol Toxicol 2004; 44: 499–523PubMedCrossRef

13.

Lindahl K, Stahle L, Bruchfeld A, et al. High-dose ribavirin in combination with standard dose peginterferon for treatment of patients with chronic hepatitis C. Hepatology 2005 Feb; 41(2): 275–9PubMedCrossRef

14.

Parlesak A, Billinger MH, Bode C, et al. Gastric alcohol dehydrogenase activity in man: influence of gender, age, alcohol consumption and smoking in a Caucasian population. Alcohol Alcohol 2002 Jul–Aug; 37(4): 388–93PubMed

15.

Baraona E, Abittan CS, Dohmen K, et al. Gender differences in pharmacokinetics of alcohol. Alcohol Clin Exp Res 2001 Apr; 25(4): 502–7PubMedCrossRef

16.

Muller C. Liver, alcohol and gender. Wien Med Wochenschr 2006 Oct; 156(19–20): 523–6PubMedCrossRef

17.

Nanji AA, Jokelainen K, Fotouhinia M, et al. Increased severity of alcoholic liver injury in female rats: role of oxidative stress, endotoxin, and chemokines. Am J Physiol Gastrointest Liver Physiol 2001 Dec; 281(6): G1348–56PubMed

18.

Sumida KD, Hill JM, Matveyenko AV. Sex differences in hepatic gluconeogenic capacity after chronic alcohol consumption. Clin Med Res 2007 Oct; 5(3): 193–202PubMedCrossRef

19.

Thurman RG. Sex-related liver injury due to alcohol involves activation of Kupffer cells by endotoxin. Can J Gastroenterol 2000 Nov; 14 Suppl. D: 129D–35DPubMed

20.

Ikejima K, Enomoto N, Iimuro Y, et al. Estrogen increases sensitivity of hepatic Kupffer cells to endotoxin. Am J Physiol 1998 Apr; 274(4 Pt 1): G669–76PubMed

21.

Englund G, Rorsman F, Ronnblom A, et al. Regional levels of drug transporters along the human intestinal tract: co-expression of ABC and SLC transporters and comparison with Caco-2 cells. Eur J Pharm Sci 2006 Nov; 29(3–4): 269–77PubMedCrossRef

22.

Tamai I, Saheki A, Saitoh R, et al. Nonlinear intestinal absorption of 5-hydroxytryptamine receptor antagonist caused by absorptive and secretory transporters. J Pharmacol Exp Ther 1997 Oct; 283(1): 108–15PubMed

23.

Jovanovic H, Lundberg J, Karlsson P, et al. Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET. Neuroimage 2008 Feb 1; 39(3): 1408–19PubMedCrossRef

24.

Salena BJ, Hunt RH. The stomach and duodenum. In: Thompson AB, Shaffer EA, editors. First principles of gastroenterology: the basis of disease and an approach to management. 2nd ed. Mississauga: Canadian Association of Gastroenterology/Astra Pharma, 1994: 135–81

25.

Stephen AM, Wiggins HS, Englyst HN, et al. The effect of age, sex and level of intake of dietary fibre from wheat on large-bowel function in thirty healthy subjects. Br J Nutr 1986 Sep; 56(2): 349–61PubMedCrossRef

26.

Butera L, Feinfeld DA, Bhargava M. Sex differences in the subunits of glutathione-S-transferase isoenzyme from rat and human kidney. Enzyme 1990; 43(4): 175–82PubMed

27.

Jacobs A. Sex differences in iron absorption. Proc Nutr Soc 1976; 35(2): 159–62PubMedCrossRef

28.

Arthur MJ, Lee A, Wright R. Sex differences in the metabolism of ethanol and acetaldehyde in normal subjects. Clin Sci (Lond) 1984; 67(4): 397–401

29.

Sowinski KM, Abel SR, Clark WR, et al. Effect of gender on the pharmacokinetics of ofloxacin. Pharmacotherapy 1999 Apr; 19(4): 442–6PubMedCrossRef

30.

Williams LR, Leggett RW. Reference values for resting blood flow to organs of man. Clin Phys Physiol Meas 1989 Aug; 10(3): 187–217PubMedCrossRef

31.

Succari M, Foglietti MJ, Percheron F. Microheterogeneity of alpha 1-acid glycoprotein: variation during the menstrual cycle in healthy women, and profile in women receiving estrogen-progestogen treatment. Clin Chim Acta 1990 Mar 15; 187(3): 235–41PubMedCrossRef

32.

Wiegratz I, Kutschera E, Lee JH, et al. Effect of four different oral contraceptives on various sex hormones and serum-binding globulins. Contraception 2003 Jan; 67(1): 25–32PubMedCrossRef

33.

Vigersky RA, Kono S, Sauer M, et al. Relative binding of testosterone and estradiol to testosterone-estradiol-binding globulin. J Clin Endocrinol Metab 1979; 49: 899–904PubMedCrossRef

34.

Roberts RK, Desmond PV, Wilkinson GR, et al. Disposition of chlordiazepoxide: sex differences and effects of oral contraceptives. Clin Pharmacol Ther 1979 Jun; 25(6): 826–31PubMed

35.

Lee JN, Chen SS, Richens A, et al. Serum protein binding of diazepam in maternal and foetal serum during pregnancy. Br J Clin Pharmacol 1982 Oct; 14(4): 551–4PubMedCrossRef

36.

Routledge PA, Stargel WW, Kitchell BB, et al. Sex-related differences in the plasma protein binding of lignocaine and diazepam. Br J Clin Pharmacol 1981 Mar; 11(3): 245–50PubMedCrossRef

37.

Yacobi A, Stoll RG, DiSanto AR, et al. Intersubject variation of warfarin binding to protein in serum of normal subjects. Res Commun Chem Pathol Pharmacol 1976 Aug; 14(4): 743–6PubMed

38.

Yacobi A, Lampman T, Levy G. Frequency distribution of free warfarin and free phenytoin fraction values in serum of healthy human adults. Clin Pharmacol Ther 1977 Mar; 21(3): 283–6PubMed

39.

Hvidberg EF, Dam M. Clinical pharmacokinetics of anticonvulsants. Clin Pharmacokinet 1976; 1(3): 161–88PubMedCrossRef

40.

Richens A. Clinical pharmacokinetics of phenytoin. Clin Pharmacokinet 1979 May–Jun; 4(3): 153–69PubMedCrossRef

41.

Young CM, Tensuan RS. Estimating the lean body mass of young women: use of skeletal measurements. J Am Diet Assoc 1963 Jan; 42: 46–51PubMed

42.

Hytten FE. Weight gain in pregnancy: 30 year of research. S Afr Med J 1981 Jul 4; 60(1): 15–9PubMed

43.

Houghton IT, Aun CS, Oh TE. Vecuronium: an anthropometric comparison. Anaesthesia 1992 Sep; 47(9): 741–6PubMedCrossRef

44.

Xue FS, Tong SY, Liao X, et al. Dose-response and time course of effect of rocuronium in male and female anesthetized patients. Anesth Analg 1997 Sep; 85(3): 667–71PubMed

45.

Ochs HR, Greenblatt DJ, Divoll M, et al. Diazepam kinetics in relation to age and sex. Pharmacology 1981; 23(1): 24–30PubMedCrossRef

46.

International Life Sciences Institute (ILSI). ILSI Risk Science Institute Working Group on Physiological Parameters Report. Washington, DC: ILSI, 1994

47.

Cooper SF, Drolet D, Dugal R. Comparative bioavailability of two oral formulations of flurazepam in human subjects. Biopharm Drug Dispos 1984 Apr–Jun; 5(2): 127–39PubMedCrossRef

48.

Greenblatt DJ, Shader RI, Franke K, et al. Kinetics of intravenous chlordiazepoxide: sex differences in drug distribution. Clin Pharmacol Ther 1977 Dec; 22(6): 893–903PubMed

49.

Aarons L, Hopkins K, Rowland M, et al. Route of administration and sex differences in the pharmacokinetics of aspirin, administered as its lysine salt. Pharm Res 1989 Aug; 6(8): 660–6PubMedCrossRef

50.

Campbell NR, Hull RD, Brant R, et al. Different effects of heparin in males and females. Clin Invest Med 1998 Apr; 21(2): 71–8PubMed

51.

Trnavska Z, Trnavsky K. Sex differences in the pharmacokinetics of salicylates. Eur J Clin Pharmacol 1983; 25(5): 679–82PubMedCrossRef

52.

Lane HY, Chang YC, Chang WH, et al. Effects of gender and age on plasma levels of clozapine and its metabolites: analyzed by critical statistics. J Clin Psychiatry 1999 Jan; 60(1): 36–40PubMedCrossRef

53.

Jokubaitis LA. Development and pharmacology of fluvastatin. Br J Clin Pract Suppl. 1996 Jan; 77A: 11–5PubMed

54.

Hooper WD, Qing MS. The influence of age and gender on the stereoselective metabolism and pharmacokinetics of mephobarbital in humans. Clin Pharmacol Ther 1990 Dec; 48(6): 633–40PubMedCrossRef

55.

Bock KW, Schrenk D, Forster A, et al. The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes. Pharmacogenetics 1994 Aug; 4(4): 209–18PubMedCrossRef

56.

Lucas D, Menez C, Girre C, et al. Cytochrome P450 2E1 genotype and chlorzoxazone metabolism in healthy and alcoholic Caucasian subjects. Pharmacogenetics 1995 Oct; 5(5): 298–304PubMedCrossRef

57.

Hunt CM, Westerkam WR, Stave GM. Effect of age and gender on the activity of human hepatic CYP3A. Biochem Pharmacol 1992 Jul 22; 44(2): 275–83PubMedCrossRef

58.

Miners JO, Robson RA, Birkett DJ. Gender and oral contraceptive steroids as determinants of drug glucuronidation: effects on clofibric acid elimination. Br J Clin Pharmacol 1984 Aug; 18(2): 240–3PubMedCrossRef

59.

Aksoy IA, Sochorova V, Weinshilboum RM. Human liver dehydroepian-drosterone sulfotransferase: nature and extent of individual variation. Clin Pharmacol Ther 1993 Nov; 54(5): 498–506PubMedCrossRef

60.

Relling MV, Lin JS, Ayers GD, et al. Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities. Clin Pharmacol Ther 1992 Dec; 52(6): 643–58PubMedCrossRef

61.

Boudikova B, Szumlanski C, Maidak B, et al. Human liver catechol-O-methyltransferase pharmacogenetics. Clin Pharmacol Ther 1990 Oct; 48(4): 381–9PubMedCrossRef

62.

Custodio JM, Wu CY, Benet LZ. Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption. Adv Drug Deliv Rev 2008 Mar 17; 60(6): 717–33PubMedCrossRef

63.

Anderson GD. Sex differences in drug metabolism: cytochrome P-450 and uridine diphosphate glucuronosyltransferase. J Gend Specif Med 2002 Jan–Feb; 5(1): 25–33PubMed

64.

Aichhorn W, Whitworth AB, Weiss EM, et al. Differences between men and women in side effects of second-generation antipsychotics [in German]. Nervenarzt 2007 Jan; 78(1): 45–52PubMedCrossRef

65.

Choi S, DiSilvio B, Unangst J, et al. Effect of chronic infusion of olanzapine and clozapine on food intake and body weight gain in male and female rats. Life Sci 2007 Sep 1; 81(12): 1024–30PubMedCrossRef

66.

Furukawa T, Kurokawa J. Regulation of cardiac ion channels via non-genomic action of sex steroid hormones: implication for the gender difference in cardiac arrhythmias. Pharmacol Ther 2007 Jul; 115(1): 106–15PubMedCrossRef

67.

Ljunggren H. Studies on body composition; with special reference to the composition of obesity tissue and non-obesity tissue. Acta Endocrinol Suppl (Copenh) 1957; 25 Suppl. 33: 1–58

68.

Cunningham JJ. Body composition and resting metabolic rate: the myth of feminine metabolism. Am J Clin Nutr 1982 Oct; 36(4): 721–6PubMed

69.

Mattison DR, Thomford PJ. The mechanisms of action of reproductive toxicants. Toxicol Pathol 1989; 17(2): 364–76PubMedCrossRef

70.

Gaudry SE, Sitar DS, Smyth DD, et al. Gender and age as factors in the inhibition of renal clearance of amantadine by quinine and quinidine. Clin Pharmacol Ther 1993 Jul; 54(1): 23–7PubMedCrossRef

71.

Berg UB. Differences in decline in GFR with age between males and females: reference data on clearances of inulin and PAH in potential kidney donors. Nephrol Dial Transplant 2006 Sep; 21(9): 2577–82PubMedCrossRef

72.

Hytten FE, Chemberlain G. Clinical physiology in obstetrics. Oxford: Blackwell Scientific Publications, 1980

73.

Silvaggio T, Mattison DR. Setting occupational health standards: toxicokinetic differences among and between men and women. J Occup Med 1994 Aug; 36(8): 849–54PubMed

74.

Davison JM, Dunlop W. Renal hemodynamics and tubular function normal human pregnancy. Kidney Int 1980 Aug; 18(2): 152–61PubMedCrossRef

75.

Dean M, Stock B, Patterson RJ, et al. Serum protein binding of drugs during and after pregnancy in humans. Clin Pharmacol Ther 1980 Aug; 28(2): 253–61PubMedCrossRef

76.

DeCherney AH, Nathan L, Goodwin TM, et al., editors. Current diagnosis & treatment: obstetrics & gynecology. 10th ed. New York: McGraw-Hill, 2006

77.

Leblhuber F, Neubauer C, Peichl M, et al. Age and sex differences of dehydroepiandrosterone sulfate (DHEAS) and cortisol (CRT) plasma levels in normal controls and Alzheimer’s disease (AD). Psychopharmacology (Berl) 1993; 111(1): 23–6CrossRef

78.

Tanaka K, Shimizu N, Imura H, et al. Human corticotropin-releasing hormone (hCRH) test: sex and age differences in plasma ACTH and cortisol responses and their reproducibility in healthy adults. Endocr J 1993 Oct; 40(5): 571–9PubMedCrossRef

79.

Vierhapper H, Nowotny P, Waldhausl W. Sex-specific differences in cortisol production rates in humans. Metabolism 1998 Aug; 47(8): 974–6PubMedCrossRef

80.

Rathore SS, Wang Y, Krumholz HM. Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med 2002 Oct 31; 347(18): 1403–11PubMedCrossRef

81.

Ostrom NK. Women with asthma: a review of potential variables and preferred medical management. Ann Allergy Asthma Immunol 2006 May; 96(5): 655–65PubMedCrossRef

82.

Miller AA, De Silva TM, Jackman KA, et al. Effect of gender and sex hormones on vascular oxidative stress. Clin Exp Pharmacol Physiol 2007 Oct; 34(10): 1037–43PubMedCrossRef

83.

Kharasch ED, Mautz D, Senn T, et al. Menstrual cycle variability in midazolam pharmacokinetics. J Clin Pharmacol 1999 Mar; 39(3): 275–80PubMed

84.

Shah AK, Laboy-Goral L, Scott N, et al. Pharmacokinetics and safety of oral eletriptan during different phases of the menstrual cycle in healthy volunteers. J Clin Pharmacol 2001 Dec; 41(12): 1339–44PubMedCrossRef

85.

Loebstein R, Lalkin A, Koren G. Pharmacokinetic changes during pregnancy and their clinical relevance. Clin Pharmacokinet 1997 Nov; 33(5): 328–43PubMedCrossRef

86.

Mattison DR, Blann E, Malek A. Physiological alterations during pregnancy: impact on toxicokinetics. Fundam Appl Toxicol 1991 Feb; 16(2): 215–8PubMedCrossRef

87.

Harris RZ, Tsunoda SM, Mroczkowski P, et al. The effects of menopause and hormone replacement therapies on prednisolone and erythromycin pharmacokinetics. Clin Pharmacol Ther 1996 Apr; 59(4): 429–35PubMedCrossRef

88.

Umeh OC, Currier JS. Sex differences in pharmacokinetics and toxicity of antiretroviral therapy. Expert Opin Drug Metab Toxicol 2006 Apr; 2(2): 273–83PubMedCrossRef

89.

Dubois D, Petitcolas J, Temperville B, et al. Treatment of hypertension in pregnancy with beta-adrenoceptor antagonists. Br J Clin Pharmacol 1982; 13(Suppl. 2): 375S–8SPubMedCrossRef

90.

Badger TM, Hidestrand M, Shankar K, et al. The effects of pregnancy on ethanol clearance. Life Sci 2005 Sep 9; 77(17): 2111–26PubMedCrossRef

91.

Ho PC, Triggs EJ, Bourne DW, et al. The effects of age and sex on the disposition of acetylsalicylic acid and its metabolites. Br J Clin Pharmacol 1985 May; 19(5): 675–84PubMedCrossRef

92.

Hebert MF, Carr DB, Anderson GD, et al. Pharmacokinetics and pharmacodynamics of atenolol during pregnancy and postpartum. J Clin Pharmacol 2005 Jan; 45(1): 25–33PubMedCrossRef

93.

Cho N, Ito T, Saito T. Clinical studies on cefazolin in the field of obstetrics and gynecology. Chemotherapy (Tokyo) 1970; 18: 377–82

94.

Mattison D, Zajicek A. Gaps in knowledge in treating pregnant women. Gend Med 2006 Sep; 3(3): 169–82PubMedCrossRef

95.

Philipson A, Stiernstedt G, Ehrnebo M. Comparison of the pharmacokinetics of cephradine and cefazolin in pregnant and non-pregnant women. Clin Pharmacokinet 1987 Feb; 12(2): 136–44PubMedCrossRef

96.

Overholser BR, Kays MB, Forrest A, et al. Sex-related differences in the pharmacokinetics of oral ciprofloxacin. J Clin Pharmacol 2004 Sep; 44(9): 1012–22PubMedCrossRef

97.

Tang YL, Mao P, Li FM, et al. Gender, age, smoking behaviour and plasma clozapine concentrations in 193 Chinese inpatients with schizophrenia. Br J Clin Pharmacol 2007 Jul; 64(1): 49–56PubMedCrossRef

98.

Luxford AM, Kellaway GS. Pharmacokinetics of digoxin in pregnancy. Eur J Clin Pharmacol 1983; 25(1): 117–21PubMedCrossRef

99.

Philipson A, Sabath LD, Charles D. Erythromycin and clindamycin absorption and elimination in pregnant women. Clin Pharmacol Ther 1976 Jan; 19(1): 68–77PubMed

100.

Woodhead JC, Drulis JM, Nelson SE, et al. Gender-related differences in iron absorption by preadolescent children. Ped Res 1991; 29: 435–9CrossRef

101.

Reigner BG, Welker HA. Factors influencing elimination and distribution of fleroxacin: metaanalysis of individual data from 10 pharmacokinetic studies. Antimicrob Agents Chemother 1996 Mar; 40(3): 575–80PubMed

102.

Schou M, Amdisen A. Lithium in pregnancy. Lancet 1970 Jun 27; 1(7661): 1391PubMedCrossRef

103.

Nosten F, Karbwang J, White NJ, et al. Mefloquine antimalarial prophylaxis in pregnancy: dose finding and pharmacokinetic study. Br J Clin Pharmacol 1990 Jul; 30(1): 79–85PubMedCrossRef

104.

Lew KH, Ludwig EA, Milad MA, et al. Gender-based effects on methyl-prednisolone pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther 1993 Oct; 54(4): 402–14PubMedCrossRef

105.

Hogstedt S, Lindberg B, Rane A. Increased oral clearance of metoprolol in pregnancy. Eur J Clin Pharmacol 1983; 24(2): 217–20PubMedCrossRef

106.

Carcas AJ, Guerra P, Frias J, et al. Gender differences in the disposition of metronidazole. Int J Clin Pharmacol Ther 2001 May; 39(5): 213–8PubMed

107.

Kanto J, Sjovall S, Erkkola R, et al. Placental transfer and maternal midazolam kinetics. Clin Pharmacol Ther 1983 Jun; 33(6): 786–91PubMedCrossRef

108.

Mesnil F, Mentre F, Dubruc C, et al. Population pharmacokinetic analysis of mizolastine and validation from sparse data on patients using the non-parametric maximum likelihood method. J Pharmacokinet Biopharm 1998 Apr; 26(2): 133–161PubMed

109.

Molinaro M, Villani P, Regazzi MB, et al. Pharmacokinetics of ofloxacin in elderly patients and in healthy young subjects. Eur J Clin Pharmacol 1992; 43(1): 105–7PubMedCrossRef

110.

Callaghan JT, Bergstrom RF, Ptak LR, et al. Olanzapine: pharmacokinetic and pharmacodynamic profile. Clin Pharmacokinet 1999 Sep; 37(3): 177–93PubMedCrossRef

111.

Konieczna L, Chmielewska A, Lamparczyk H. Influence of sex on the pharmacokinetics of ciprofloxacin and ofloxacin. Chemotherapy 2006; 52(3): 111–21PubMedCrossRef

112.

Meyer MC, Straughn AB, Mhatre RM, et al. Variability in the bioavailability of phenytoin capsules in males and females. Pharm Res 2001 Mar; 18(3): 394–7PubMedCrossRef

113.

Meffin PJ, Brooks PM, Sallustio BC. Alterations in prednisolone disposition as a result of time of administration, gender and dose. Br J Clin Pharmacol 1984 Apr; 17(4): 395–404PubMedCrossRef

114.

Smith MT, Livingstone I, Eadie MJ, et al. Chronic propranolol administration during pregnancy: maternal pharmacokinetics. Eur J Clin Pharmacol 1983; 25(4): 481–90PubMedCrossRef

115.

El-Eraky H, Thomas SH. Effects of sex on the pharmacokinetic and pharmacodynamic properties of quinidine. Br J Clin Pharmacol 2003 Aug; 56(2): 198–204PubMedCrossRef

116.

Adamus M, Gabrhelik T, Marek O. Influence of gender on the course of neuromuscular block following a single bolus dose of cisatracurium or rocuronium. Eur J Anaesthesiol 2008 Jul; 25(7): 589–95PubMedCrossRef

117.

Pleym H, Spigset O, Kharasch ED, et al. Gender differences in drug effects: implications for anesthesiologists. Acta Anaesthesiol Scand 2003 Mar; 47(3): 241–59PubMedCrossRef

118.

Hartter S, Wetzel H, Hammes E, et al. Nonlinear pharmacokinetics of fluvoxamine and gender differences. Ther Drug Monit 1998 Aug; 20(4): 446–9PubMedCrossRef

119.

Kaplan SA, Weinfeld RE, Abruzzo CW, et al. Pharmacokinetic profile of sulfisoxazole following intravenous, intramuscular, and oral administration to man. J Pharm Sci 1972; 61(5): 773–8PubMedCrossRef

120.

Loi CM, Parker BM, Cusack BJ, et al. Aging and drug interactions: III. Individual and combined effects of cimetidine and cimetidine and ciprofloxacin on theophylline metabolism in healthy male and female non-smokers. J Pharmacol Exp Ther 1997 Feb; 280(2): 627–37PubMed

121.

Perucca E, Ruprah M, Richens A. Altered drug binding to serum proteins in pregnant women: therapeutic relevance. J R Soc Med 1981 Jun; 74(6): 422–6PubMed

122.

Nomura T. Pharmacokinetics and pharmacodynamics of vecuronium bromide. J Anesth 1992 Jan; 6(1): 28–37PubMedCrossRef

123.

Krecic-Shepard ME, Barnas CR, Slimko J, et al. Gender-specific effects on verapamil pharmacokinetics and pharmacodynamics in humans. J Clin Pharmacol 2000 Mar; 40(3): 219–30PubMedCrossRef

124.

Krecic-Shepard ME, Barnas CR, Slimko J, et al. Faster clearance of sustained release verapamil in men versus women: continuing observations on sex-specific differences after oral administration of verapamil. Clin Pharmacol Ther 2000 Sep; 68(3): 286–92PubMedCrossRef

Titel: Sex Differences in Pharmacokinetics and Pharmacodynamics
verfasst von: Dr Offie P. Soldin
Donald R. Mattison
Publikationsdatum: 01.03.2009
Verlag: Springer International Publishing
Erschienen in: Clinical Pharmacokinetics / Ausgabe 3/2009
Print ISSN: 0312-5963
Elektronische ISSN: 1179-1926
DOI: https://doi.org/10.2165/00003088-200948030-00001

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2009

Population Pharmacokinetics of Orally Administered Duloxetine in Patients

Effect of Pregnancy on the Pharmacokinetics of Antihypertensive Drugs

Population Pharmacokinetics and Dosing Recommendations for Cisplatin during Intraperitoneal Peroperative Administration

Effect of the Cytochrome P450 2C19 Inhibitor Omeprazole on the Pharmacokinetics and Safety Profile of Bortezomib in Patients with Advanced Solid Tumours, Non-Hodgkin’s Lymphoma or Multiple Myeloma

Defining the Role of Macrophages in Local Moxifloxacin Tissue Concentrations using Biopsy Data and Whole-Body Physiologically Based Pharmacokinetic Modelling